Clincosm LogoSign in Get a demo

Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications

Sponsor
Sohag University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06112197
Collaborator
(none)
100
Enrollment
1
Location
17
Anticipated Duration (Months)
5.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The Metabolic Score for Insulin Resistance (METS-IR) is a metabolic index developed with the aim to quantify peripheral insulin sensitivity in humans; it was first described under the name METS-IR by Bello-Chavolla et al in 2018. It was developed by the Metabolic Research Disease Unit at the Institute National de Ciencias Médicas Salvador Zubirán and validated against the euglycemic hyperinsulinemic clamp and the frequently-sampled intravenous glucose tolerance test in Mexican population.It is a non-insulin-based alternative to insulin-based methods to quantify peripheral insulin sensitivity and an alternative to the Homeostatic Model Assessment (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI).

    Very limited research correlate between visceral obesity and microvascular complications in type 2 diabetic patients and how can the metabolic score for insulin resistance predict visceral obesity and microvascular complications in type2 diabetic patients. In this study the investigators will search for these correlations.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Study of Visceral Fat in Type 2diabetic Patients and Its Relation to Microvascular Complications
    Anticipated Study Start Date :
    Jan 5, 2024
    Anticipated Primary Completion Date :
    Jan 5, 2025
    Anticipated Study Completion Date :
    Jun 5, 2025

    Outcome Measures

    Primary Outcome Measures

    1. correlation between METS IR and visceral fat in type 2 diabetes [one year]

      Study the cor relation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age > 18 years Both male and female subjects Subjects capable of giving consent and voluntarily willing to participate in the study
    Exclusion Criteria:
    • Chronic kidney disease patients Any nondiabetic nephropathy patients Patients affected by hypertension Patients affected by ocular disorders Neuropathies of other etiologies like chronic liver disease patients, alcoholics, or drug addicts Critically ill patients of type 2 diabetes mellitus Patients who have not given consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mahmoud Soliman Sohag Egypt 00000

    Sponsors and Collaborators

    • Sohag University

    Investigators

    • Study Director: mahmoud soliman, Sohag University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mahmoud Ahmed Soliman, Ass.lecturer of internal medicine, Sohag University
    ClinicalTrials.gov Identifier:
    NCT06112197
    Other Study ID Numbers:
    • Soh-Med-23-10-13MD
    First Posted:
    Nov 1, 2023
    Last Update Posted:
    Nov 2, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Insulin Resistance

    Study Results

    No Results Posted as of Nov 2, 2023